title: TAS-102 for metastatic refractory colorectal cancer.
authors.forename: Sean
authors.initials: S
authors.lastname: Cleghorn
mesh_terms: D005260:Female; D006801:Humans; D008297:Male; D015179:Colorectal Neoplasms / Q000188:drug therapy / Q000401:mortality / Q000473:pathology; D018572:Disease-Free Survival; D004338:Drug Combinations; D009362:Neoplasm Metastasis; D009367:Neoplasm Staging; D011379:Prognosis; D011759:Pyrrolidines; D018570:Risk Assessment; D016019:Survival Analysis; D013941:Thymine; D016896:Treatment Outcome; D014271:Trifluridine / Q000009:adverse effects / Q000627:therapeutic use; D014498:Uracil / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use
chemical_list: D004338:Drug Combinations; D011759:Pyrrolidines; D013941:Thymine; D014271:Trifluridine; C000613803:trifluridine tipiracil drug combination; D014498:Uracil